BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 25248574)

  • 1. Congenital GATA1-mutated myeloproliferative disorder in trisomy 21 complicated by placental fetal thrombotic vasculopathy.
    Loh TJ; Lian DW; Iyer P; Lam JC; Kuick CH; Aung AC; Chang KT
    Hum Pathol; 2014 Nov; 45(11):2364-7. PubMed ID: 25248574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fetal hydrops and hepatosplenomegaly in the second half of pregnancy: a sign of myeloproliferative disorder in fetuses with trisomy 21.
    Smrcek JM; Baschat AA; Germer U; Gloeckner-Hofmann K; Gembruch U
    Ultrasound Obstet Gynecol; 2001 May; 17(5):403-9. PubMed ID: 11380964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [GATA1 analysis in myeloproliferative disorders associated to trisomy 21].
    Fuster Soler JL; Norton A; Galera Miñarro A; Bermúdez Cortés M; Llinares Riestra ME; Ortuño Giner F
    An Pediatr (Barc); 2011 Jan; 74(1):31-7. PubMed ID: 20870473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient myeloproliferative disorder with partial trisomy 21.
    Takahashi T; Inoue A; Yoshimoto J; Kanamitsu K; Taki T; Imada M; Yamada M; Ninomiya S; Toki T; Terui K; Ito E; Shimada A
    Pediatr Blood Cancer; 2015 Nov; 62(11):2021-4. PubMed ID: 26138905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe TMD/AMKL with GATA1 mutation in a stillborn fetus with Down syndrome.
    Heald B; Hilden JM; Zbuk K; Norton A; Vyas P; Theil KS; Eng C
    Nat Clin Pract Oncol; 2007 Jul; 4(7):433-8. PubMed ID: 17597708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphologic and GATA1 sequencing analysis of hematopoiesis in fetuses with trisomy 21.
    Hoeller S; Bihl MP; Tzankov A; Chaffard R; Hirschmann P; Miny P; Kühne T; Bruder E
    Hum Pathol; 2014 May; 45(5):1003-9. PubMed ID: 24746204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk for leukemia in infants without Down syndrome who have transient myeloproliferative disorder.
    Cushing T; Clericuzio CL; Wilson CS; Taub JW; Ge Y; Reichard KK; Winter SS
    J Pediatr; 2006 May; 148(5):687-9. PubMed ID: 16737888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transient myeloproliferative disorder with trisomy 12.
    Basu B; Gupta V
    Pediatr Hematol Oncol; 2010 Apr; 27(3):233-6. PubMed ID: 20367267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial perinatal liver disease and fetal thrombotic vasculopathy.
    Ernst LM; Grossman AB; Ruchelli ED
    Pediatr Dev Pathol; 2008; 11(2):160-3. PubMed ID: 17990937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient myeloproliferative disorder and GATA1 mutation in neonates with and without Down syndrome.
    Tsai MH; Hou JW; Yang CP; Yang PH; Chu SM; Hsu JF; Chiang MC; Huang HR
    Indian J Pediatr; 2011 Jul; 78(7):826-32. PubMed ID: 21287369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fetal origin of the GATA1 mutation in identical twins with transient myeloproliferative disorder and acute megakaryoblastic leukemia accompanying Down syndrome.
    Shimada A; Xu G; Toki T; Kimura H; Hayashi Y; Ito E
    Blood; 2004 Jan; 103(1):366. PubMed ID: 14684662
    [No Abstract]   [Full Text] [Related]  

  • 12. [Transient myeloproliferative disorder in a neonate without Down syndrome].
    Adam M; Vincenot A; Gouraud F; Harvel C; Perot C; Portnoi MF; Andre-Kerneis E; Giraudier S; Leverger G; Favier R
    Ann Biol Clin (Paris); 2007; 65(5):569-73. PubMed ID: 17913678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of GATA1 mutations in Down syndrome transient myeloproliferative disorder and myeloid leukemia.
    Alford KA; Reinhardt K; Garnett C; Norton A; Böhmer K; von Neuhoff C; Kolenova A; Marchi E; Klusmann JH; Roberts I; Hasle H; Reinhardt D; Vyas P;
    Blood; 2011 Aug; 118(8):2222-38. PubMed ID: 21715302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal atresia occurring in association with placental fetal thrombotic vasculopathy: a case report with literature review.
    Lian DW; Lam JC; Aung AC; Li FX; Chang KT
    Pediatr Dev Pathol; 2013; 16(1):28-31. PubMed ID: 22989172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute megakaryoblastic leukemia without GATA1 mutation after transient myeloproliferative disorder in an infant without Down syndrome.
    Inaba H; Londero M; Maurer SH; Onciu M; Ge Y; Taub JW; Rubnitz JE; Raimondi SC
    J Clin Oncol; 2011 Mar; 29(9):e230-3. PubMed ID: 21205752
    [No Abstract]   [Full Text] [Related]  

  • 16. [GATA1-mutation associated leukemia in children with trisomy 21 mosaic].
    Reinhardt D; Reinhardt K; Neuhoff C; Sander A; Klusmann JH; Pekrun A; Sauerbrey A; von Stackelberg A; Rössig C; Creutzig U; Kolenova A
    Klin Padiatr; 2012 Apr; 224(3):153-5. PubMed ID: 22513796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fetal thrombotic vasculopathy accompanied by fetal growth restriction.
    Kim TH; Lee HH; Chung SH; Park J; Kwak JJ
    J Matern Fetal Neonatal Med; 2014 Apr; 27(6):643-5. PubMed ID: 23796264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of acute megakaryoblastic leukemia from a minor clone in a Down syndrome patient with clinically overt transient myeloproliferative disorder.
    Xu G; Kato K; Toki T; Takahashi Y; Terui K; Ito E
    J Pediatr Hematol Oncol; 2006 Oct; 28(10):696-8. PubMed ID: 17023834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of 2 isogenic clones from a patient with Trisomy 21 and a GATA1 mutation.
    Takasaki K; Kumar SS; Gagne A; French DL; Chou ST
    Stem Cell Res; 2023 Jun; 69():103098. PubMed ID: 37084616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congenital transient myeloproliferative disorder progressing to acute myeloid leukemia in Down's syndrome: a case report.
    Prabhu PD; V G; Niveditha SR; Gayathri BR; Keshavamurthy SR
    Indian J Pathol Microbiol; 2004 Jan; 47(1):48-50. PubMed ID: 15471129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.